Medtronic (MDT) Change in Receivables (2014 - 2026)

Medtronic has disclosed Change in Receivables across 13 years of filings, most recently posting -$224.0 million for Q3 2026.

• In Q3 2026, Change in Receivables rose 22.22% year-over-year to -$224.0 million; the TTM figure through Jul 2026 stood at $264.0 million (up 3.53% YoY), while the FY2026 annual figure was $200.0 million, down 53.81% from the prior year.
• Change in Receivables came in at -$224.0 million for Q3 2026 at Medtronic, down from $287.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $435.0 million in Q4 2022 to a low of -$288.0 million in Q3 2025.
• Average Change in Receivables over 5 years is $88.5 million, with a median of $62.0 million recorded in 2023.
• Year-over-year, Change in Receivables surged 232.06% in 2022 and tumbled 533.33% in 2026.
• Over 5 years, Change in Receivables stood at $435.0 million in 2022, then plunged by 35.4% to $281.0 million in 2023, then increased by 3.56% to $291.0 million in 2024, then fell by 26.46% to $214.0 million in 2025, then plunged by 204.67% to -$224.0 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$224.0 million in Q3 2026, $287.0 million in Q2 2026, and -$13.0 million in Q1 2026.